Picture of Bionik Laboratories logo

BNKL — Bionik Laboratories Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+115.75%
3m+220.04%
6m+28.93%
1yr-18.66%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-313.23%
Return on Equity-335.3%
Operating Margin-783%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Bionik Laboratories EPS forecast chart

Profile Summary

Bionik Laboratories Corp. is a robotics company, which provides rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. It uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and deliver recovery for patients with neurological or mobility impairments. It has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development. Its InMotion ARM, and InMotion ARM/HAND products are robotic therapies for the upper limbs. In addition to these fully developed, clinical rehabilitation solutions, it is also developing InMotion Home, which is an upper extremity product that allows the patient to extend their therapy for as long as needed while rehabilitating at home. Its other products are InMotion Robots and InMotion CONNECT.

Directors

Last Annual
March 31st, 2022
Last Interim
March 31st, 2022
Incorporated
June 25th, 2013
Public Since
June 12th, 2012
No. of Shareholders
318
No. of Employees
12
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
6,767,114

BNKL Share Price Performance

Upcoming Events for BNKL

Q1 2023 Bionik Laboratories Corp Earnings Release

Q2 2023 Bionik Laboratories Corp Earnings Release

Bionik Laboratories Corp Annual Shareholders Meeting

Similar to BNKL

Picture of 20/20 Genesystems logo

20/20 Genesystems

us flag iconPink Sheets on Nasdaq

Picture of Accustem Sciences logo

Accustem Sciences

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

Picture of Health Sciences logo

Health Sciences

us flag iconPink Sheets on Nasdaq

FAQ

Or unlock with your email

Or unlock with your email